Enhancing the Quality of Rivaroxaban Exposure Estimates Using Prothrombin Time in the Absence of Pharmacokinetic Sampling
Solms, Alexander, Frede, Matthias, Berkowitz, Scott D., Hermanowski‐Vosatka, Anne, Kubitza, Dagmar, Mueck, Wolfgang, Spiro, Theodore E., Willmann, Stefan, Yan, Xiaoyu, Zhang, Liping, Garmann, DirkМова:
english
Журнал:
CPT: Pharmacometrics & Systems Pharmacology
DOI:
10.1002/psp4.12444
Date:
July, 2019
Файл:
PDF, 9.22 MB
english, 2019